Department of Bioengineering, College of Engineering, Temple University, Philadelphia, PA, USA.
Debina Diagnostic Inc ., Newtown Square, PA, USA.
Int J Nanomedicine. 2019 Aug 12;14:6451-6464. doi: 10.2147/IJN.S209663. eCollection 2019.
We recently reported on long-term comprehensive biocompatibility and biodistribution study of fluorescent nanodiamond particles (NV)-Z-average 800nm (FNDP-(NV)) in rats. FNDP-(NV) primary deposition was found in the liver, yet liver function tests remained normal.
The present study aimed to gain preliminary insights on discrete localization of FNDP-(NV) in liver cells of the hepatic lobule unit and venous micro-vasculature. Kinetics of FDNP-(NV) uptake into liver cells surrogates in culture was conducted along with cell cytokinesis as markers of cells' viability.
Preserved liver specimens from a pilot consisting of two animals which were stained for cytoskeletal elements (fluorescein-isothiocyanate-phalloidin) were examined for distribution of FNDP-(NV) by fluorescent microscopy (FM) and Confocal-FM (CFM) using near infra-red fluorescence (NIR). Hepatocellular carcinoma cells (HepG-2) and human umbilical vein endothelial cells (HUVEC) were cultured with FNDP-(NV) and assayed for particle uptake and location using spectrophotometric technology and microscopy.
HepG-2 and HUVEC displayed rapid (<30 mins) onset and concentration-dependent FNDP-(NV) internalization and formation of peri-nuclear corona. FM/CFM of liver sections revealed FNDP-(NV) presence throughout the hepatic lobules structures marked by spatial distribution, venous microvascular spaces and parenchyma and non-parenchyma cells.
The robust presence of FNDP-(NV) throughout the hepatic lobules including those internalized within parenchyma cells and agglomerates in the liver venous micro-circulation were not associated with macro or micro histopathological signs nor vascular lesions. Cells cultures indicated normal cytokinesis in cells containing FNDP-(NV) agglomerates. Liver parenchyma cells and the liver microcirculation remain agnostic to presence of FNDP-(NV) in the sinusoids or internalized in the hepatic cells.
我们最近报道了荧光纳米金刚石颗粒(NV)-Z 平均 800nm(FNDP-(NV))在大鼠体内长期综合生物相容性和生物分布研究。FNDP-(NV)的主要沉积部位在肝脏,但肝功能检查仍正常。
本研究旨在初步了解 FNDP-(NV)在肝小叶单位的肝细胞和静脉微血管中的离散定位。研究了 FNDP-(NV)在培养的肝细胞替代物中的摄取动力学以及作为细胞活力标志物的细胞胞质分裂。
对来自两个动物的试点研究的保存肝脏标本进行了细胞骨架成分(异硫氰酸荧光素-鬼笔环肽)染色,通过荧光显微镜(FM)和近红外荧光(NIR)的共聚焦-FM(CFM)检查 FNDP-(NV)的分布。培养肝细胞癌细胞(HepG-2)和人脐静脉内皮细胞(HUVEC),并用分光光度技术和显微镜检测粒子摄取和位置。
HepG-2 和 HUVEC 表现出快速(<30 分钟)的 FNDP-(NV)内化和核周晕形成,且与浓度相关。肝切片的 FM/CFM 显示 FNDP-(NV)存在于整个肝小叶结构中,标记为空间分布、静脉微血管空间和实质细胞和非实质细胞。
FNDP-(NV)在整个肝小叶中大量存在,包括那些被内吞到实质细胞内和在肝静脉微循环中聚集的 FNDP-(NV),与宏观或微观组织病理学迹象或血管病变无关。细胞培养表明,含有 FNDP-(NV)聚集物的细胞中有正常的胞质分裂。肝实质细胞和肝微循环对 FNDP-(NV)在窦状隙中的存在或在肝细胞内的内化均无反应。